ALLO
Price
$1.92
Change
-$0.16 (-7.73%)
Updated
Dec 18, 04:06 PM (EDT)
70 days until earnings call
CRBU
Price
$1.79
Change
-$0.15 (-7.73%)
Updated
Dec 18, 04:10 PM (EDT)
96 days until earnings call
Ad is loading...

ALLO vs CRBU

Header iconALLO vs CRBU Comparison
Open Charts ALLO vs CRBUBanner chart's image
Allogene Therapeutics
Price$1.92
Change-$0.16 (-7.73%)
Volume$5.93K
CapitalizationN/A
Caribou Biosciences
Price$1.79
Change-$0.15 (-7.73%)
Volume$300
CapitalizationN/A
ALLO vs CRBU Comparison Chart
Loading...
ALLO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
CRBU
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ALLO vs. CRBU commentary
Dec 18, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ALLO is a Hold and CRBU is a Hold.

COMPARISON
Comparison
Dec 18, 2024
Stock price -- (ALLO: $2.07 vs. CRBU: $1.94)
Brand notoriety: ALLO and CRBU are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ALLO: 92% vs. CRBU: 80%
Market capitalization -- ALLO: $434.02M vs. CRBU: $175.67M
ALLO [@Biotechnology] is valued at $434.02M. CRBU’s [@Biotechnology] market capitalization is $175.67M. The market cap for tickers in the [@Biotechnology] industry ranges from $486.73B to $0. The average market capitalization across the [@Biotechnology] industry is $2.67B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ALLO’s FA Score shows that 0 FA rating(s) are green whileCRBU’s FA Score has 1 green FA rating(s).

  • ALLO’s FA Score: 0 green, 5 red.
  • CRBU’s FA Score: 1 green, 4 red.
According to our system of comparison, CRBU is a better buy in the long-term than ALLO.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ALLO’s TA Score shows that 4 TA indicator(s) are bullish while CRBU’s TA Score has 2 bullish TA indicator(s).

  • ALLO’s TA Score: 4 bullish, 6 bearish.
  • CRBU’s TA Score: 2 bullish, 8 bearish.
According to our system of comparison, ALLO is a better buy in the short-term than CRBU.

Price Growth

ALLO (@Biotechnology) experienced а -5.48% price change this week, while CRBU (@Biotechnology) price change was -4.43% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -3.65%. For the same industry, the average monthly price growth was +1.45%, and the average quarterly price growth was +4.23%.

Reported Earning Dates

ALLO is expected to report earnings on Feb 26, 2025.

CRBU is expected to report earnings on Mar 24, 2025.

Industries' Descriptions

@Biotechnology (-3.65% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ALLO($434M) has a higher market cap than CRBU($176M). ALLO YTD gains are higher at: -35.514 vs. CRBU (-66.143). CRBU has higher annual earnings (EBITDA): -161.7M vs. ALLO (-256.67M). ALLO has more cash in the bank: 292M vs. CRBU (228M). CRBU has less debt than ALLO: CRBU (26.6M) vs ALLO (85.1M). CRBU has higher revenues than ALLO: CRBU (11.5M) vs ALLO (43K).
ALLOCRBUALLO / CRBU
Capitalization434M176M247%
EBITDA-256.67M-161.7M159%
Gain YTD-35.514-66.14354%
P/E RatioN/AN/A-
Revenue43K11.5M0%
Total Cash292M228M128%
Total Debt85.1M26.6M320%
FUNDAMENTALS RATINGS
ALLO: Fundamental Ratings
ALLO
OUTLOOK RATING
1..100
61
VALUATION
overvalued / fair valued / undervalued
1..100
97
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
97
PRICE GROWTH RATING
1..100
82
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ALLOCRBU
RSI
ODDS (%)
Bullish Trend 2 days ago
90%
Bearish Trend 6 days ago
90%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
85%
Bullish Trend 2 days ago
77%
Momentum
ODDS (%)
Bearish Trend 2 days ago
88%
Bearish Trend 2 days ago
90%
MACD
ODDS (%)
Bearish Trend 2 days ago
87%
Bearish Trend 2 days ago
89%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
88%
Bearish Trend 2 days ago
89%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
88%
Bearish Trend 2 days ago
90%
Advances
ODDS (%)
Bullish Trend 2 days ago
80%
Bullish Trend 10 days ago
81%
Declines
ODDS (%)
Bearish Trend 6 days ago
87%
Bearish Trend 6 days ago
88%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
82%
Bearish Trend 2 days ago
90%
Aroon
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
View a ticker or compare two or three
Ad is loading...
ALLO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
CRBU
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
GEBCX9.90N/A
N/A
Goldman Sachs ESG Em Mkts Eq C
FDCAX43.16-0.17
-0.39%
Fidelity Capital Appreciation
JHERX20.81-0.11
-0.53%
JHancock Equity Income C
FSCHX14.39-0.08
-0.55%
Fidelity Select Chemicals
EISGX18.52-0.26
-1.38%
Eaton Vance Small-Cap I

ALLO and

Correlation & Price change

A.I.dvisor indicates that over the last year, ALLO has been loosely correlated with FATE. These tickers have moved in lockstep 58% of the time. This A.I.-generated data suggests there is some statistical probability that if ALLO jumps, then FATE could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ALLO
1D Price
Change %
ALLO100%
+0.49%
FATE - ALLO
58%
Loosely correlated
-6.00%
NTLA - ALLO
57%
Loosely correlated
-1.87%
CRBU - ALLO
56%
Loosely correlated
+1.57%
CRSP - ALLO
55%
Loosely correlated
+0.88%
PRME - ALLO
52%
Loosely correlated
-3.00%
More

CRBU and

Correlation & Price change

A.I.dvisor indicates that over the last year, CRBU has been loosely correlated with ALLO. These tickers have moved in lockstep 56% of the time. This A.I.-generated data suggests there is some statistical probability that if CRBU jumps, then ALLO could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CRBU
1D Price
Change %
CRBU100%
+1.57%
ALLO - CRBU
56%
Loosely correlated
+0.49%
ARVN - CRBU
52%
Loosely correlated
+0.58%
BEAM - CRBU
52%
Loosely correlated
-1.21%
FATE - CRBU
51%
Loosely correlated
-6.00%
AXON - CRBU
50%
Loosely correlated
-2.09%
More